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ABSTRACT 
Objective: The aim of the present study was to prepare the ondansetron hydrochloride Mouth Dissolving Tablets (MDTs) followed by its 
comparison with ethical and non-ethical (generic) marketed tablets. 
Methods: Prior to the formulation, drug excipient compatibility study was carried out by FTIR spectroscopy. The λmax was determined by UV 
spectroscopy. The ondansetron hydrochloride MDTs were prepared by direct compression method using Sodium Starch Glycolate (SSG) as super 
disintegrant and camphor as a sublimating agent. Then the prepared MDTs were subjected to evaluation of post compression parameters such as 
thickness and diameter, weight variation, wetting time, hardness, friability, disintegration and dissolution. The results obtained were compared 
with that of ethical and non-ethical marketed ondansetron hydrochloride 4 mg tablets. 
Results: The λmax was found at 310 nm. FTIR study revealed that excipients used in the prepared formulations are compatible with the drug. The 
thickness and diameter was in the range of 2.646 to 3.27 mm and 6.0 to 8.12 mm, respectively. Friability was in the range of 0.43 to 0.88 % and had 
a slightly higher friability (1.27%) for sublimated tablets. Wetting time and disintegration time were in the range of 15 to 40 sec and 23 to 50 sec, 
respectively. The 100 % drug release was found within 180 sec for all the codes. These results were then compared with non-ethical film coated 
ondansetron marketed tablets. 
Conclusion: Ondansetron hydrochloride MDT 4 mg tablets prepared in the laboratory were under specified IP limits. The experimental findings 
demonstrated that any of these ethical and non-ethical tablets of ondansetron hydrochloride can be selected, advised by the physician or 
pharmacist, as per the patient’s need and economical status. 
Keywords: Hardness, Friability, Disintegration, Dissolution, Ondansetron hydrochloride, Mouth dissolving tablets, FTIR spectroscopy, Quality 
control tests, Post compression parameters, MDT 




Oral administration of tablets is still the best choice of method to treat 
various disorders over several novel drug delivery systems [1]. Among 
oral route administrations, fast dissolving drug delivery system is 
more suitable when comparing to the conventional means due to the 
patients convenience [2]. MDT disintegrates within seconds in 
patient’s mouth and therefore used in the condition of dysphasia [3]. 
Ondansetron hydrochloride is chemically 9-methyl-3-[(2-methyl-
1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one 
hydrochloride selective serotonin receptor blocker (5 hydroxy 
tryptamine type 3) which is used as an antiemetic in the cancer 
chemotherapy [2, 4]. 
For testing the quality of a finished tablet product, evaluation 
parameters such as hardness, friability, disintegration time, and 
dissolution profile study are more precise since it reflects the 
therapeutic effectiveness and bioavailability of the drug [5]. Some of 
the studies showed dissimilar results in post compression 
parameters among different marketed products that contain same 
active pharmaceutical ingredients [6-8]. In some conditions tablets 
with same drug or drug content may not be giving a same 
therapeutic response, which may be due to the different rate and 
extent of absorption, varying purity of the drug, and by using various 
types of excipients etc. [9-11]. These reports demonstrate the 
importance of comparative study of different marketed products 
with the same active ingredients. 
The availability of numerous brands of ondansetron hydrochloride 
MDT in the drug market makes clinicians and pharmacists difficult to 
select a suitable brand or the possibility of alternative use. Prescribing 
physicians should also develop awareness regarding the 
interchangeability of multisource branded generic drug products. 
Despite the considerable use in India, there are no reports on the 
comparative study of various brands of ondansetron hydrochloride 
MDT tablets marketed in India; hence the present investigation has 
been carried out. In this study an attempt has been made to compare 
the different evaluation parameters like thickness and diameter, 
weight variation, wetting time, hardness, friability, disintegration time, 
and dissolution profile of ethical and non-ethical marketed tablets of 
ondansetron hydrochloride with tablets prepared in the laboratory. 
 
 
Fig. 1: Chemical structure of ondansetron hydrochloride 
 
MATERIALS AND METHODS 
Materials 
Ondansetron hydrochloride pure drug was received from Zydus 
Cadila Ltd. Ondansetron hydrochloride MDT 4 mg was prepared in 
the laboratory by using SSG as superdisintegrant and camphor as a 
sublimating agent. According to the availability of ondansetron 
hydrochloride 4 mg, four ethical and one non ethical tablets were 
purchased from a local pharmacy and Janaushadhi Store, Davangere, 
India respectively during Feb-2019. The different tablets are listed 
in table 1. All chemical reagents used (0.1N HCl, methylene blue and 
distilled water) were of analytical grade. 
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Table 1: List of ondansetron 4 mg tablets 
Code Name Manufacturer 
A Vomikind®-MD 4 Mankind Pharma Ltd 
B Vomiros-4MD Roussel® Laboratories Pvt Ltd 
C Ondem®-MD 4 Alkem Health Sciences 
D Onvin-4 MD Rivpra Formulation Pvt Ltd 
E Ondansetron hydrochloride MDT 4 mg (Superdisintegrants) Prepared in Laboratory 
F Ondansetron hydrochloride MDT 4 mg (Sublimation) Prepared in Laboratory 
  
Preparation of tablets by direct compression method 
By using superdisintegrant (Code E) 
Accurately weighed quantities of ingredients except lubricating 
agent were mixed in a mortar and pestle for 10 min to get a 
uniform blend. The uniform blend passed through sieve no.60. 
Magnesium stearate was added as lubricating agent. Tablets were 
prepared by direct compression method using 6 mm flat punches 
on a 10 station rotary compression machine(Rimek Nanikadi, 
Gujarat) [12, 13]. The formula was obtained by performing trial 
and error method and best-fit formula was selected as shown in 
table 2. 
 
Table 2: Formulation for code E 
Ingredients Formula 
Ondansetron hydrochloride 4.0 mg 
Sodium starch glycolate 6.0 mg 
Microcrystalline cellulose 37.0 mg 
Mannitol 45.0 mg 
Talc 5.0 mg 
Magnesium stearate 3.0 mg 
 
By sublimation technique (Code F) 
Accurately weighed quantity of ondansetron hydrochloride, sublimating 
agent (camphor), and crospovidone were mixed in mortar and pestle 
and passed through the sieve no 60. Magnesium stearate and talc were 
added as lubricating agent. The tablets were prepared by direct 
compression method using 6 mm punches on a 10 station rotary 
compression machine. The prepared tablets were heated in a hot air 
oven at 60 °C until it attains a constant weight (complete removal of 
volatilizable component camphor). Heating causes the evaporation of 
camphor leaving behind pores on the surface of the tablet, which causes 
faster disintegration of the tablet compared to conventional mouth 
dissolving tablet [14, 15]. The formula was obtained by performing trial 
and error method and best-fit formula was selected as shown in table 3. 
 
Table 3: Formulations for code F 
Ingredients Formula 
Ondansetron hydrochloride 4 mg 
Crospovidone 9 mg 
Camphor 4 mg 
Lactose 74 mg 
Magnesium stearate 4 mg 
Talc 5 mg 
 
Determination of absorption maxima of ondansetron hydrochloride 
Standard solution of 12µg/ml ondansetron hydrochloride was 
prepared and scanned in the range of 400-200 nm by taking 0.1N 
HCl as blank. The linearity plot was constructed by preparing the 
standard solution of drug in between 4-24 μg/ml, where the drug 
obeys beer’s lamberts law [16]. The absorbance for the respective 
concentration is depicted in table 4. 
 
Table 4: Data for standard plot of ondansetron hydrochloride in 0.1N HCl 
S. No. Concentration (μg/ml) Absorbance Standard deviation (n=3) 
1 0 0 0 
2 4 0.145 ±0.127 
3 8 0.281 ±0.095 
4 12 0.44 ±0.048 
5 16 0.58 ±0.097 
6 20 0.73 ±0.062 
7 24 0.85 ±0.091 
 
Drug-excipient compatibility study 
Compatibility studies of ondansetron hydrochloride pure drug and 
formulations are performed by using fourier transform infrared 
spectroscopy (BrukerAlpha FTIR, Bruker). KBr disc method was 
used for the analysis and the spectra of the samples were obtained in 
the range of 4000 to 500 cm-1. 
Evaluation of post compression parameters 
All codes of tablets were subjected to the following quality control tests. 
Thickness and diameter 
Tablet was kept in between two arms of a digital micrometer for 
measuring the thickness and diameter. The procedure was repeated 
for 5 tablets and the average value was calculated [17]. 
Weight variation 
20 tablets of each brands and generic were weighed individually 
using digital electronic balance (Shimadzu, Kyoto, Japan) and the 
average weight was calculated from the total weight. The percentage 
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deviations from the mean value were calculated by using the 
following equation [18-20]. 
100%. ×  W2)/W2]- [(W1 =iation Weight var  
Where, W1 = Initial weight of the tablet 
W2 = Average weight of the tablet 
According to official guidelines,±10% is permitted for tablets 
weighing 80 mg or less. For tablets weighing 80-250 mg and above 
250 mg,±7.5% and±5% are acceptable respectively [7]. 
Wetting time 
Five circular tissue papers of 10 cm diameter were placed in a 
petridish with a 10 cm diameter. Ten ml of water containing 
methylene blue, a water-soluble dye, was added to the petridish. A 
tablet was carefully placed on the surface of the tissue paper and the 
time required for water to reach the upper surface of the tablet was 
noted as a wetting time [21]. 
Friability 
Friability testing is carried out to check how much mechanical stress 
can be tolerated by the tablets during its manufacturing, 
distribution, and handling. The instrument used to determine the 
friability is called Friabilator or friability tester. 10 tablets were 
weighed and placed in the friability test apparatus EF2-USP. The 
apparatus was operated for 4 min ie., 100 rotations (25 rpm) and the 
tablets remained intact were weighed and recorded [22]. For 
calculating % friability, the equation given below was used. Friability 
less than 1% is considered as acceptable [23-26]. 
100% ×  weight)](Initial weight)/ Final - weight [(Initial = Friability %  
Hardness 
The resistance of a tablet for chipping and breakage while 
transporting can be measured by testing its hardness [27]. 
Thehardness of the tablet was tested using Monsanto hardness 
tester (Sheetal scientific industries, Ahmedabad) and expressed in 
terms of kg/cm2. A tablet was placed vertically in between the 
spindle and anvil on the Monsanto hardness tester and the pointer 
on the reading were set to zero. Then the pressure was applied 
slowly in order to break the tablet and the reading was noted. The 
same procedure was followed for 10 tablets and the average of 
pressure required to break each tablet was recorded [28]. 
Disintegration time 
The in vitro disintegration were carried out by electro lab digital 
tablet disintegration tester ED-2L. 6 tablets from each code were 
placed in 6 tubes of the basket and disc were placed above the tablet 
in order prevent the escape of the tablets from the tubes while 
operating. The assembly then dipped in one litre beaker filled with 
700 ml of distilled water and maintained the temperature at 37±0.5 
°C. The basket moved up and down around 5 to 6 cm vertically and 
the time at which the tablets completely pass through the sieves was 
recorded [12, 29]. 
Dissolution studies 
In vitro dissolution studies were carried out by using the tablet 
dissolution tester (USP XX III), shown in fig. 2. Paddle type apparatus 
was used in accordance with USP specifications [30]. The dissolution 
medium of 900 ml of 0.1N HCl (PH 1.2) was transferred to the basket 
and temperature was maintained at 37±0.5 °C [27]. After reaching 
the bath temperature and basket temperature 37±0.5 °C, a tablet 
was placed in the basket and the paddle made to rotate at 50 rpm. 
Aliquots of 5 ml were collected at an interval of 30, 60, 90, 120, 150, 
and 180 sec respectively by replacing pre-warmed dissolution 
medium to 37±0.5 °C. The drug concentration was analysed by UV 
spectrophotometer at 310 nm. 
 
 
Fig. 2: Dissolution apparatus USP-XXIII (Electro lab, Mumbai) 
 
RESULTS AND DISCUSSION 
Absorption maxima of ondansetron hydrochloride 
Standard plot of ondansetron hydrochloride is shown in fig. 3. The 
linearity was observed in the range of 4-24 μg/ml with a correlation 
coefficient of 0.999. The maximum absorbance of ondansetron 
hydrochloride was detected at 249 nm and depicted in fig. 4. It is 
observed that 310 nm can also be selected as λmax since there was 
no much difference found in the absorbance value. There are more 




Fig. 3: Standard plot of ondansetron hydrochloride in 0.1 N HCl at 310 nm 
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Fig. 4: UV spectrum of ondansetron hydrochloride 
 
Drug-excipient compatibility study 
Compatibility studies of ondansetron hydrochloride with other 
ingredients in both the formulations of code F and G were separately 
studied prior to the formulation of tablets. The FTIR spectrum 
obtained for ondansetron hydrochloride and the data are shown in 
fig. 5 and table 5 respectively. The bands of ondansetron 
hydrochloride pure drug matched with that of the standard IR 
spectrum of ondansetron hydrochloride given in literature reveals 
the purity of the drug. All the characteristic peaks of ondansetron 
hydrochloride in pure form were present in the spectrum of both the 
formulations as shown in fig. 6 and 7 respectively. It indicated there 
was no interaction between the drug and excipient in both the 
formulations; hence compatibility was confirmed. 
 
Table 5: FTIR spectrum of pure ondansetron hydrochloride 
S. No. Bond (stretching) Wave number (cm-1) 
Literature value [31] Found value 
1 N-H 3000-3700 3478.42 
2 C=O 1600-1900 1692.09 
3 C=N 1600-1900 1622.73 
4 C-H 1300-1500 1455.25 
5 C-C 800-1200 912.81 
 
 
Fig. 5: FTIR spectrum of pure ondansetron hydrochloride 
 
 
Fig. 6: FTIR spectrum of formulation code F 
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Fig. 7: FTIR spectrum of formulation code G 
 
Thickness and diameter  
The thickness and diameter of all the tablets lie between 2.646 to 
3.27 mm and 6 to 8.12 mm, respectively. The very minor deviations 
in the thickness and diameter, which reveals the proper operation 
and weighing of the powder blend during tablet manufacture. 
Weight variation 
All codes of tablets were passed the weight variation test (table 7) 
according to official guidelines since the percentage deviation was 
under±7.5%. The uniformity of the weight implies proper tooling of 
the tablet punching machine. 
 
Table 6: Data of thickness and diameter of ondansetron hydrochloride MDTs 
Code Thickness Diameter 
A 3±0.071 7±0.052 
B 2.9±0.005 8.12±0.008 
C 2.646±0.071 6.5±0.015 
D 2.72±0.084 6.97±0.012 
E 3.27±0.010 6±0.007 
F 2.998±0.411 6±0.009 
 mean±SD, n=5 
 
Table 7: Weight variation studies of ondansetron hydrochloride MDTs 
S. No. Code Average of 20 tablets Percentage deviation Inference 
1 A 102.1 1.37 Passes 
2 B 166.05 1.275 Passes 
3 C 97.15 1.380 Passes 
4 D 115.2 1.056 Passes 
5 E 103.05 2.089 Passes 
6 F 102.1 1.586 Passes 
 
Wetting time  
All codes of tablets were wetted within 40 sec (table 8); indicates the 
congenial porosity of the tablets. Further it enhances quick dissolution 
and disintegration. Fig. 8 represents the wetting time of code E. 
Friability 
The friability of various codes of tablets is shown below in table 9. A 
perusal to table 9 indicated that all codes of tablets, except code F, 
are less than 1% ensures mechanical stability. Code F tablets were 
prepared in the laboratory by sublimation technique. It is observed 
that the pores formed by sublimation of camphor in code F tablets 
may be the reason to get higher friability value more than 1 %. For 
them, additional care should be taken in order to prevent 
mechanical stress during processing, handling, and transportation. 
Disintegration time 
The disintegration time of all codes, except E, was passable 
according to USP where mouth dissolving tablets have disintegration 
time standard value as low as 30 sec (table 10). 
 
Table 8: Wetting time data of ondansetron hydrochloride MDTs 
S. No. Code Wetting time (sec) 
1 A 15 
2 B 24 
3 C 14 
4 D 15 
5 E 40 
 6 F 26 
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Table 9: Friability data of ondansetron hydrochloride MDTs 
Code Weight of 10 tablets Difference in 
the weights (W1-W2) 
% Friability 
Before test W1 After test W2 
A 1.018 1.009 0.009 0.88 
B 1.650 1.640 0.01 0.60 
C 0.983 0.978 0.005 0.51 
D 1.155 1.150 0.005 0.43 
E 1.039 1.031 0.008 0.77 
F 1.026 1.013 0.013 1.27 
 
 
Fig. 8: Wetting time of code E 
 
Table 10: Disintegration time data of studies of ondansetron hydrochloride MDTs 
S. No. Code Disintegration time (sec) 
1 A 23 
2 B 25 
3 C 20 
4 D 28 
5 E 35 
6 F 26 
 
Hardness  
Perusal to table 11, it was found that poor hardness of all the codes 
of tablets. It may be due to the poor flow properties of the powder, 
air entrapment, and moisture content of the powder. But it can be 
tolerated since the tablets should be disintegrated within 1 min after 
placing it on the tongue [36]. The less hardness of the MDTs may be 
due the less compression force, which make the fast disintegration 
of a tablet [37]. Code D tablets have shown the highest hardness 
(2.94 kg/cm2) among all the codes of tablets. 
Dissolution studies 
Dissolution profiles of the tablets are shown in fig. 9. Code A tablets 
had shown a faster release of 100.93% at 120 sec. When compared 
to all other codes of tablets, Code F tablets released slowly but 
within the limits (3 min) as specified in IP [3]. Hence all the codes of 
tablets are within the official prescribed limits. 
Comparison of ondansetron MDT 4 mg with Non ethical 
ondansetron 4 mg tablets 
The generic ondansetron hydrochloride 4 mg tablets obtained from 
the Janaushadhi Store, Davangere was film coated. It had an average 
weight of 144.14 with a percentage deviation of 1.23 %, which was 
acceptable. Friability of the tablets was less (0.34 %) when 
compared to other ethical tablets. The tablet disintegrated within 3 
min and the time required for wetting was 58 sec. The hardness 
(4.11±0.2079 kg/cm2) of the tablets was acceptable and high when 
compared to the ethical tablets. 99.5±0.6250% (in 40 min) of the 
drug released was within the official limit. 
  
Table 11: Hardness ondansetron hydrochloride MDTs 
S. No. Code Hardness (kg/cm2) 
1 A 0.97±0.216 
2 B 1.28±0.103 
3 C 1.05±0.151 
4 D 2.94±0.135 
5 E 1.69±0.185 
6 F 1.23±0.170 
 mean±SD, n=10 
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Fig. 9: Dissolution profile ondansetron hydrochloride MDTs 
 
CONCLUSION 
Ondansetron hydrochloride MDT 4 mg tablets were prepared in the 
laboratory and it was under specified IP limits. The experimental 
findings demonstrated that any of these ethical and non-ethical tablets 
of ondansetron hydrochloride can be prescribed by the physician, as 
per the patient's needs. The film coated marketed tablet (Janaushadh) 
was compared with other ethical and formulated tablets and various 
parameters were evaluated and compared. The ethical and formulated 
tablets results were on the upper edge in comparison to film coated 
tablets. It is further suggested that post-marketing scrutiny like 
bioavailability studies must be performed for formulated and 
marketed ondansetron hydrochloride MDTs so as to ensure their 
safety, efficacy, and bioequivalence. 
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